Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial

European Journal of Heart Failure

Volumn 17, Issue 7, 2015, Pages 725-734

  MacDonald, Michael R ^a   She, Lilin ^b   Doenst, Torsten ^c   Binkley, Philip F ^d   Rouleau, Jean L ^e   Tan, Ru San ^f   Lee, Kerry L ^g   Miller, Alan B ^h   Sopko, George ⁱ   Szalewska, Dominika ^j   Waclawiw, Myron A ⁱ   Dabrowski, Rafal ^k   Castelvecchio, Serenella ^l   Adlbrecht, Christopher ^m   Michler, Robert E ⁿ   Oh, Jae K ^o   Velazquez, Eric J ^g   Petrie, Mark C ^p  

^a CHANGI GENERAL HOSPITAL   (Singapore)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e MONTREAL HEART INSTITUTE   (Canada)

^f DEPARTMENT OF CARDIOLOGY   (Singapore)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j MEDICAL UNIVERSITY OF GDANSK   (Poland)

^k INSTITUTE OF CARDIOLOGY   (Poland)

^l IRCCS POLICLINICO SAN DONATO   (Italy)

^m MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁿ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^o MAYO CLINIC   (United States)

^p UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

Coronary artery bypass graft; Diabetes; Heart failure; Ischaemic heart disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; INSULIN; LOOP DIURETIC AGENT; WARFARIN;

ADULT; ALL CAUSE MORTALITY; ARTICLE; ATRIAL FIBRILLATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; HEART ARREST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; INTRAAORTIC BALLOON PUMP; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SURGICAL INFECTION; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84947862570     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.288     Document Type: Article

References (19)

1. MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJV,. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 2008; 29: 1224-1240.
2. Kannel WB, Hjortland M, Castelli WP,. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
3. Kannel WB, McGee DL,. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
4. O'Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, Lee KL, Califf RM, Jones RH,. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002; 90: 101-107.
5. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761-1769.
6. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RYK, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV,. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice. Circulation 2012; 126: 3097-3137.
7. BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE,. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515.
8. Farkouh ME, Domanski M, Sleeper L a, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson E a, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V,. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375-2384.
9. Velazquez EJ, Lee KL, Deja M a, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau J-L,. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011; 364: 1607-1616.
10. Jones RH, White H, Velazquez EJ, Shaw LK, Pietrobon R, Panza JA, Bonow RO, Sopko G, O'Connor CM, Rouleau JL,. STICH (surgical treatment for ischemic heart failure) trial enrollment. J Am Coll Cardiol 2010; 56: 490-498.
11. Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH,. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2007; 134: 1540-1547.
12. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau J-L, Lee KL, STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360: 1705-1717.
13. Oh JK, Velazquez EJ, Menicanti L, Pohost GM, Bonow RO, Lin G, Hellkamp AS, Ferrazzi P, Wos S, Rao V, Berman D, Bochenek A, Cherniavsky A, Rogowski J, Rouleau JL, Lee KL, STICH Investigators. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J 2013; 34: 39-47.
14. Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL,. Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction. J Am Coll Cardiol 2014; 64: 553-561.
15. Boudina S, Abel ED,. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3223.
16. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJJ, Schalkwijk CG, Bronzwaer JGF, Diamant M, Borbély A, van der Velden J, Stienen GJM, Laarman GJ, Niessen HWM, Paulus WJ,. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008; 117: 43-51.
17. Melduni RM, Suri RM, Seward JB, Bailey KR, Ammash NM, Oh JK, Schaff HV, Gersh BJ,. Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-operative atrial fibrillation. J Am Coll Cardiol 2011; 58: 953-961.
18. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ,. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 1994; 90: 2772-2779.
19. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S,. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000; 21: 1368-1375.